Immune Landscape and an RBM38-Associated Immune Prognostic Model with Laboratory Verification in Malignant Melanoma

Immune Landscape and an RBM38-Associated Immune Prognostic Model with Laboratory Verification in Malignant Melanoma

Background: Current studies have revealed that RNA-binding protein RBM38 is closely related to tumor development, while its role in malignant melanoma remains unclear. Therefore, this research aimed to investigate the function of RBM38 in melanoma and the prognosis of the disease. Methods: Functiona...

Full description

Bibliographic Details
Main Authors:	Jinfang Liu, Jun Xu, Binlin Luo, Jian Tang, Zuoqiong Hou, Zhechen Zhu, Lingjun Zhu, Gang Yao, Chujun Li
Format:	Article
Language:	English
Published:	MDPI AG 2022-03-01
Series:	Cancers
Subjects:	melanoma RBM38 prognostic signature tumor microenvironment immune checkpoint therapy
Online Access:	https://www.mdpi.com/2072-6694/14/6/1590

Similar Items

The role of c-Myc-RBM38 loop in the growth suppression in breast cancer
by: Xiao-Xia Li, et al.
Published: (2017-04-01)

Identification of a novel immune-related gene signature for prognosis and the tumor microenvironment in patients with uveal melanoma combining single-cell and bulk sequencing data
by: Wanpeng Wang, et al.
Published: (2023-01-01)

Rbm38 Reduces the Transcription Elongation Defect of the <i>SMEK2</i> Gene Caused by Splicing Deficiency
by: Shintaro Muraoka, et al.
Published: (2020-11-01)

PTEN expression is upregulated by a RNA-binding protein RBM38 via enhancing its mRNA stability in breast cancer
by: Xu-Jie Zhou, et al.
Published: (2017-10-01)

Multiple epigenetic modification profiles reveal the tumor immune microenvironment and clinical outcomes of uveal melanoma
by: Xinshuai Nan, et al.
Published: (2023-04-01)

RBM38 Reverses Sorafenib Resistance in Hepatocellular Carcinoma Cells by Combining and Promoting lncRNA-GAS5
by: Xing Gao, et al.
Published: (2023-05-01)

RBM38 plays a tumor-suppressor role via stabilizing the p53-mdm2 loop function in hepatocellular carcinoma
by: Jiazhou Ye, et al.
Published: (2018-09-01)

Identification and Validation of Immune- and Stemness-Related Prognostic Signature of Melanoma
by: Yan Zhang, et al.
Published: (2021-11-01)

Construction and Verification of the Molecular Subtype and a Novel Prognostic Signature Based on Inflammatory Response-Related Genes in Uveal Melanoma
by: Feng Zhang, et al.
Published: (2023-01-01)

The RNA-binding protein RBM24 regulates lipid metabolism and SLC7A11 mRNA stability to modulate ferroptosis and inflammatory response
by: Jin Zhang, et al.
Published: (2022-11-01)

Identification of a prognostic six-immune-gene signature and a nomogram model for uveal melanoma
by: Binghua Yang, et al.
Published: (2023-01-01)

Construction of immunotherapy-related prognostic gene signature and small molecule drug prediction for cutaneous melanoma
by: Jiahua Xing, et al.
Published: (2022-07-01)

Identification of an Immune-Related Prognostic Signature Associated With Immune Infiltration in Melanoma
by: Nian Liu, et al.
Published: (2020-08-01)

Commentary: A novel signature of 23 immunity related gene pairs is prognostic of cutaneous melanoma
by: Ruihuan Shen, et al.
Published: (2023-06-01)

A Comprehensive Prognostic and Immune Infiltration Analysis of RBM4 in Pan-Cancer
by: Jia-Jun Ding, et al.
Published: (2024-02-01)

Effects of RNA methylation N6-methyladenosine regulators on malignant progression and prognosis of melanoma
by: Jinfang Liu, et al.
Published: (2021-08-01)

Optimization of eIF4E-Binding Peptide Pep8 to Disrupt the RBM38-eIF4E Complex for Induction of p53 and Tumor Suppression
by: Christopher A. Lucchesi, et al.
Published: (2022-04-01)

Evaluate the immune-related eRNA models and signature score to predict the response to immunotherapy in thyroid carcinoma
by: Pu Wu, et al.
Published: (2022-10-01)

Construction and Validation of a Novel Immunosignature for Overall Survival in Uveal Melanoma
by: Chufeng Gu, et al.
Published: (2021-09-01)

N6-Methyladenosine regulator RBM15B acts as an independent prognostic biomarker and its clinical significance in uveal melanoma
by: Tianyu Wang, et al.
Published: (2022-08-01)

Prognostic Value and Immunological Characteristics of a Novel RNA Binding Protein Signature in Cutaneous Melanoma
by: Jun Tian, et al.
Published: (2021-08-01)

Senescence-Related lncRNA Signature Predicts Prognosis, Response to Immunotherapy and Chemotherapy in Skin Cutaneous Melanoma
by: Kefan Lin, et al.
Published: (2023-04-01)

A Newly Established Cuproptosis-Related Gene Signature for Predicting Prognosis and Immune Infiltration in Uveal Melanoma
by: Wei Huang, et al.
Published: (2023-07-01)

Risk Based Monitoring (RBM): A global study focusing on perception and merits among clinical investigational sites
by: Prajna P. Kumar, et al.
Published: (2016-12-01)

Variants of RBM20 gene in pediatric patients with dilated cardiomyopathy
by: A. M. Kiselev, et al.
Published: (2019-11-01)

Comprehensive research into prognostic and immune signatures of transcription factor family in breast cancer
by: Qing Wu, et al.
Published: (2023-04-01)

An Integrated Analysis of Prognostic Signature and Immune Microenvironment in Tongue Squamous Cell Carcinoma
by: Yi Jin, et al.
Published: (2022-07-01)

Cancer-Specific Immune Prognostic Signature in Solid Tumors and Its Relation to Immune Checkpoint Therapies
by: Shaoli Das, et al.
Published: (2020-09-01)

Risk Score Prediction Model of Prognosis in GC Patients by Age and Gender Combined With m6A Modification Genes FTO and RBM15
by: Limin Yue, et al.
Published: (2022-03-01)

A combined aging and immune prognostic signature predict prognosis and responsiveness to immunotherapy in melanoma
by: Wenchang Lv, et al.
Published: (2022-08-01)

Comprehensive analysis identifies IFI16 as a novel signature associated with overall survival and immune infiltration of skin cutaneous melanoma
by: Hanwen Wang, et al.
Published: (2021-12-01)

Cuproptosis-related lncRNAs predict the clinical outcome and immune characteristics of hepatocellular carcinoma
by: Hongfei Zhu, et al.
Published: (2022-09-01)

Liquid-liquid phase separation throws novel insights into treatment strategies for skin cutaneous melanoma
by: Jianlan Liu, et al.
Published: (2023-05-01)

Construction of a Ferroptosis-Related Gene Signature for Predicting Survival and Immune Microenvironment in Melanoma Patients
by: Zeng N, et al.
Published: (2021-10-01)

LncRNA CALML3-AS1 suppresses papillary thyroid cancer progression via sponging miR-20a-5p/RBM38 axis
by: Xiaozhou Zhang, et al.
Published: (2022-03-01)

Immune Landscape and Classification in Lung Adenocarcinoma Based on a Novel Cell Cycle Checkpoints Related Signature for Predicting Prognosis and Therapeutic Response
by: Jian Yang, et al.
Published: (2022-05-01)

Identification of a necroptosis-related prognostic gene signature associated with tumor immune microenvironment in cervical carcinoma and experimental verification
by: Kai Sun, et al.
Published: (2022-10-01)

Fibroblast growth factor receptor family mutations as a predictive biomarker for immune checkpoint inhibitors and its correlation with tumor immune microenvironment in melanoma
by: Wengang Zhang, et al.
Published: (2022-11-01)

A lactate metabolism-related signature predicting patient prognosis and immune microenvironment in ovarian cancer
by: Linhua Zhu, et al.
Published: (2024-03-01)

RBM5-AS1 promotes radioresistance in medulloblastoma through stabilization of SIRT6 protein
by: Chuanying Zhu, et al.
Published: (2021-07-01)